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Arterial injury leads to activation of thrombin,
which has a central role in the hemostatic process.
Thrombin is the most potent physiologic activator
of platelets and participates in several proteolytic
processes that regulate blood coagulation. Throm-
bin is a potent physiologic activator of vascular
smooth muscle contraction.1,2 Thrombin may also
contribute to hemostasis by inducing vasospasm
and narrowing the defect in an injured arterial wall.
Vasospasm requires sustained vascular smooth
muscle contraction and activation of mitogen-acti-
vated protein (MAP) kinase has been implicated in
the maintenance of force in vascular smooth muscle
contraction.3-5 MAP kinase has been shown to acti-
vate a novel kinase, mitogen-activated protein
kinase–activated protein-2 kinase (MAPKAP2
kinase), which has been shown to phosphorylate a
small heat shock protein, HSP27.6-8 Thrombin
stimulation of platelets leads to increased phospho-
rylation of HSP27.9 Bombesin-induced contrac-
tions of rectal sphincter smooth muscle are also
associated with increased phosphorylation of
HSP27.10 Increased phosphorylation of a group of
previously unidentified, 27 kd proteins has been
associated with agonist-induced contraction of vas-
cular smooth muscles.11 HSP27 also associates with
the cytoskeleton and modulates actin filament
dynamics.12-15
We hypothesized that activation of MAPKAP2
kinase and increased phosphorylation of HSP27
might modulate thrombin-induced vasospasm. In
this investigation, we identified HSP27 as a major
phosphoprotein in vascular smooth muscle, exam-
ined the activation of MAPKAP2 kinase, and deter-
mined the changes in phosphorylation and distribu-
tion of isoforms of HSP27 associated with throm-
bin-induced vascular smooth muscle contraction.
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Purpose: Thrombin mediates hemostasis by promoting thrombus development and
vasospasm, which reduces the size of the arterial injury. Thrombin stimulation of vascu-
lar smooth muscle is associated with activation of mitogen-associated protein kinase.
The purpose of this investigation was to determine the subsequent cellular signaling
events in thrombin-stimulated vascular smooth muscle contraction.
Methods: Contractile responses of bovine carotid artery smooth muscle were determined
in a muscle bath and compared with phosphorylation events with two-dimensional gel
electrophoresis. The activity of a novel kinase, mitogen-activated protein kinase-activat-
ed protein-2 kinase (MAPKAP2 kinase), was determined by immunoprecipitation and a
phosphotransferase assay. A small heat shock protein, HSP27, was identified with
immunoblotting.
Results: Thrombin induces contraction of vascular smooth muscle and is associated with
increased activity of MAPKAP2 kinase and increased phosphorylation of HSP27.
Multiple isoforms of HSP27 are the predominant phosphoproteins in vascular smooth
muscle, and peptide mapping suggests that the isoforms of HSP27 are structurally relat-
ed and phosphorylated within similar peptide sequences.
Conclusions: Activation of the MAPKAP2 kinase pathway and phosphorylation of
HSP27 are associated with thrombin-induced contraction of vascular smooth muscle. 
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MATERIALS AND METHODS
Materials
Bovine thrombin, N-2-hydroxyethylpiperazine-
N´-2 ethanesulfonic acid (HEPES), ethylenedi-
aminetetraacetic acid (EDTA), ethylene glycol-bis(b -
amino ethyl ether) N,N,N´,N´-tetraacetic acid
(EGTA), (3-[(3-cholamidopropyl) dimethylammo-
nio]-1-propanesulfonate (CHAPS), 3-[N-morpholi-
no propanesulfonic acid (MOPS), and all other ana-
lytic grade chemicals were obtained from Sigma
Chemical Corporation (St. Louis, Mo.). 125I-protein
A and 32[P]-orthophosphate were obtained from
Dupont-New England Nuclear (Belerica, Mass.).
MAPKAP2 antibodies, MAPKAP2 substrate peptide,
and purified MAPKAP2 kinase were from Upstate
biotechnology (Lake Placid, N.Y.). Recombinant
HSP27 was from StressGen Corporation (Victoria,
British Columbia, Canada). Anti-HSP27 antibodies
were obtained from Dr. M. Welsh (University of
Michigan, Ann Arbor, Mich.),16 reagents for elec-
trophoresis were from Bio-Rad Laboratories
(Hercules, Ca.), and molecular weight standards were
from Amersham (Rainbow Markers, Arlington, Ill.).
Smooth muscle contractile responses
Bovine calf carotid arteries were harvested at a
local abattoir and prepared as previously described.17
In brief, the arteries were opened longitudinally and
the endothelium gently denuded by rubbing the inti-
ma with a cotton-tipped applicator.18 Transverse sec-
tions (1 mm) were cut and mounted in a tissue bath
with silk suture. One end was anchored to a fixed
glass pipette and the other to a force transducer
(Grass Instrument Corp., Quincy, Mass.). Tension
was recorded on a stripchart recorder (Gould
Instrument Corp., Norcross, Ga.). Strips were equi-
librated for 60 minutes at 37oC in water-jacketed
chambers containing bicarbonate buffer (120 mM
NaCl, 4.7 mM KCl, 1.0 mM MgSO4, 1.0 mM
NaH2PO4, 10 mM glucose, 1.5 mM CaCl2, and 25
mM Na2HCO3). The strips were gassed with 95%
O2 and 5% CO2 and maintained at pH 7.4. The max-
imal contractile length was adjusted with repeated
additions of 110 mM KCl (with equimolar replace-
ment of NaCl). All data are reported as a percentage
of the maximal response to 110 mM KCl. Thrombin
was reconstituted in water and added directly to the
muscle bath at dilutions of greater than 1:100.
MAPKAP2 kinase activity assay
MAPKAP2 kinase activity was determined
according to the method of Stokoe et al.6 Strips of
bovine carotid artery remained as controls or were
stimulated with thrombin (300 U/ml for 10 min-
utes) and homogenized in 50 mM Tris, pH 7.5, 1
mM EDTA, 1 mM EGTA, 0.5 mM Na3VO4, 0.1%
2-mercaptoethanol, 1% Triton X-100, 5 mM sodium
pyrophosphate, 10 mM sodium glycerophosphate,
0.1 mM phenylmethylsulfonyl fluoride (PMSF), 1
µg/ml aprotinin, 1 µg/ml leupeptin, and 50 mM
NaF with a Tekmar Tissuemizer (Cincinnati, Ohio).
The samples were centrifuged (10,000g), and 100 µl
of arterial homogenates (containing 400 µg of pro-
tein) were immunoprecipitated with 5 µg of MAP-
KAP2 antibody for 2 hours at 4oC. The immuno-
complex was washed, and the MAPKAP2 activity
was determined with a phosphotransferase assay.
The reactions contained the immunocomplex, 10 µl
of assay buffer (20 mM MOPS, pH 7.2, 25 mM b -
glycerol phosphate, 5 mM EGTA, 1 mM sodium
orthovanadate [Na3VO4], 1 mM dithiothreotol
[DTT]), 10 µl of MAPKAP2 substrate peptide (1
mM), and 10 µl of [g -32P]ATP (specific activity of
1000 cpm/pmol). The reactions were incubated for
30 minutes at 30oC with gentle shaking and stopped
by blotting onto P81 paper (Whatman, Clifton,
N.J.). The papers were washed three times with
0.75% phosphoric acid and once with acetone; they
were dried and counted in a scintillation counter.
Purified MAPKAP2 kinase (1.0 U) was used as a
positive control.
Whole cell phosphorylation, two-dimensional
gel electrophoresis, and immunoblotting
Bovine carotid artery smooth muscle strips were
equilibrated for 60 minutes in bicarbonate buffer.
The strips were placed in low-phosphate buffer (10
mM HEPES, pH 7.4, 140 mM NaCl, 4.7 mM KCl,
1.0 mM MgCl2, 1.5 mM CaCl2, 10 mM glucose,
and 0.3 mM NaH2PO4) for an additional 60 min-
utes; 250 µCi/ml [32P]-orthophosphate was then
added for 1 hour to label intracellular ATP pools.
Thrombin (300 U/ml) was added for the last 10
minutes of incubation, and the reaction stopped by
immersion in a dry ice and acetone slurry. The tissue
was crushed with mortar and pestle under liquid N2.
The powder was resuspended in homogenization
buffer (20 mM HEPES, pH 7.4, 20 mM sucrose,
100 mM NaF, 15 mM EDTA, 2mM EGTA, 1 mM
PMSF, and 1.3% sodium dodecyl sulfate [SDS]).
Whole-cell phosphorylation changes were deter-
mined by two-dimensional gel electrophoresis.19 In
brief, the samples were precipitated with acetone
and reconstituted in 9 M urea and 2% CHAPS 100
mM dithiothretol. After protein weighing, isoelec-
tric focusing (IEF) with 2% v/v ampholytes (pH
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1:1, 4-6:5-7; LKB Pharmacia, Upsala, Sweden) was
performed for 1 hour at 100 V, 1 hour at 200 V, and
19 hours 24 minutes at 500 V in a slab gel. After fix-
ation and staining, the IEF lanes were placed on
Tris-tricene gels20 and run for 21 hours at 90 V. The
gels were transferred to Immobilon, and autoradi-
ographs were obtained. The blots were then blocked
with TBS-milk (10 mM Tris, pH 7.4, 150 mM
NaCl, 5% milk), washed with TBS-Tween (10 mM
Tris, pH 7.4, 150 mM NaCl, 0.5% Tween 20), and
probed with mouse anti-HSP27 antibody (1:5000
in TBS-milk for 1 hour). Immunoreactive proteins
were detected with 125I-goat anti-mouse IgG
(1:2000 in block buffer) and a PhosphorImager
(Molecular Dynamics, Sunnyvale, Ca).
Peptide mapping
Peptide mapping was performed according to
the method of Cleveland et al.21 The spots corre-
sponding to the different isoforms of HSP27 were
cut from two-dimensional gels and rehydrated with
125 mM Tris (pH 6.8) and 0.1% SDS for 1 hour.
The rehydrated gel pieces were placed in the wells
of a 15% SDS-PAGE gel and overlayed with 10 m g
of Staphalococcus V8 protease in 125 mM Tris HCl,
pH 6.8, 0.1% SDS, and 15% glycerol. The gel was
run at 150 V until the dye front reached the end of
the gel. The gels were dehydrated in graded
methanol (to 100% methanol), dried, and exposed
to Kodak XAR-5 film.
In vitro phosphorylation of recombinant HSP27
by MAPKAP2 kinase
Recombinant HSP27 (0.5 µg) was incubated in
a reaction mixture containing 20 mM MOPS, 25
mM b -glycerol phosphate, 1 mM Na3VO4, 1 mM
DTT, and 0.1 U of MAPKAP2 kinase. The reaction
was initiated by the addition of 200 µM [g -32P]ATP
(800 cpm/pmol) and allowed to run for 20 minutes
at 30oC. The reaction was stopped by the addition
of SDS (1.3% final concentration). The proteins
were precipitated with acetone, reconstituted in 9 M
urea and 2% CHAPS, and separated on two-dimen-
sion gels as described previously.
Statistical analysis
Values are reported as the mean ± SEM.
Statistical differences between groups were deter-
mined with one-way repeated measures analysis of
variance (ANOVA) on ranks with Sigma Stat soft-
ware (Jandel Scientific, San Rafael, Ca.). A p value of
less than 0.05 was considered significant, and n
refers to the number of animals examined. Each ves-
sel was tested in duplicate. Phosphorylated proteins
on two-dimensional gels were quantitated with a
PhosphorImager and ImageQuant software (Mole-
cular Dynamics, Sunnyvale, Ca.).
RESULTS
Physiologic contractile responses to thrombin
Thrombin stimulation (300 U/ml) produced
rapidly developing, sustained contractions of bovine
carotid artery smooth muscle (Fig. 1). The magni-
tude of the contractile response to thrombin (300
U/ml) was 107 ± 5.4% (n = 8) of the response to
high levels of extracellular KCl (110 mM). Thrombin
concentrations in physiologic blood clots have been
estimated to be in the range of 150 U/ml.22 The
concentrations of thrombin that induce vascular
smooth muscle contraction in vitro are in the physi-
ologic range. Thrombin produces a dose-dependent
increase in contractile responses in bovine carotid
artery smooth muscles, with the maximal in vitro
response at 1000 U/ml of thrombin.2
MAPKAP2 kinase activation
Thrombin stimulation (300 U/ml for 10 min-
utes) of intact strips of bovine carotid artery smooth
muscle led to significant increases in MAPKAP2
kinase activity (Fig. 2). Administration of purified
MAPKAP2 kinase (1 U) led to an increase of 137 ±
32 pmoles of 32P transferred to the peptide substrate.
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Fig. 1. Thrombin-induced contraction of bovine carotid
artery smooth muscle. Strips of bovine carotid artery
smooth muscle were equilibrated in a muscle bath, and the
maximal contractile response to high extracellular KCl
(110 mM, K) was determined. The strips were washed
(W) and re-equilibrated in normal bicarbonate buffer. The
strips were then exposed to bovine thrombin (300 U/ml,
T). Contractions induced by thrombin were 107 ± 5.4% (n
= 8) of the magnitude of the response to KCl. The con-
tractions were sustained for at least 30 minutes (data not
shown). The magnitude of the contractile response
(grams) is depicted on the y axis and time (minutes) on
the x axis.
Phosphorylation of HSP27 in vascular smooth
muscles
Multiple 27 kd proteins with different isoelectric
points were present on two-dimensional gels from
homogenates of carotid arteries that had been incu-
bated in the presence of [32P]-orthophosphate (Fig.
3). Thrombin stimulation led to significant increas-
es in the phosphorylation of each of the 27 kd pro-
teins (HSP27A, 3.0 ± 0.8*-fold; HSP27B, 1.6 ±
0.6*-fold; HSP27C, 1.7 ± 0.5*-fold; and HSP27D,
2.3 ± 0.9*-fold increase over unstimulated tissue; *p
< 0.05 compared with unstimulated tissue; n = 4).
The immunoreactive isoforms of HSP27 had relative
mobility and isoelectric focusing points similar to
those of the 27 kd phosphoproteins (Fig. 3). The
phosphorylation of recombinant HSP27 with MAP-
KAP2 kinase in vitro also revealed a pattern of
migration of HSP27 on two-dimensional gels simi-
lar to the pattern that occured in situ after thrombin
stimulation (Fig. 4).
To assess the relation of the different phosphory-
lated isoforms of HSP27, we performed Cleveland
digests.21 Digests of the different phosphorylated
isoforms of HSP27 produced similar phosphopep-
tide maps (Fig. 5).
One basic isoform of HSP27 was not present on
the autoradiograph, suggesting there is a nonphos-
phorylated isoform of HSP27. Thrombin stimula-
tion significantly decreased the nonphosphorylated
isoform of HSP27 (Fig. 6). There was no difference
in the total amount of immunoreactive HSP27 in
the control and thrombin-stimulated carotid artery
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Fig. 2. Thrombin-induced activation of MAPKAP2
kinase in carotid artery. Strips of bovine carotid artery
smooth muscle were stimulated with thrombin (THR;
300 U/ml for 10 minutes) or remained unstimulated
(CONT). The strips were homogenized, and MAPKAP2
kinase was immunoprecipitated from 400 µg of protein.
The activity of MAPKAP2 kinase was determined with a
specific substrate peptide in a phosphotransferase assay.
The results are reported as the amount of 32P transferred
to the peptide. Thrombin stimulation led to a significant
increase in the activity of MAPKAP2 kinase (*p < 0.05,
paired t test; n = 6).
Fig. 3. Thrombin stimulation leads to an increase in the
phosphorylation of multiple isoforms of HSP27. Strips of
bovine carotid artery smooth muscle were phosphorylated
with [32P]-orthophosphate and remained in buffer (A and
C, control [CONT]) or were stimulated with thrombin
(300 U/ml) for 10 minutes (B and D, THR). The strips
were homogenized and the proteins separated on two-
dimensional gels and transferred to Immobilon-P. The
blots were exposed on a PhosphorImager (A and B), and
the extent of phosphorylation was determined with
ImageQuant software. The blots were then probed with
anti-HSP27 antibodies (C and D). Thrombin stimulation
led to significant (p < 0.05, ANOVA on ranks; n = 4)
increases in the phosphorylation of the myosin light chains
(m; 2.8 ± 0.8-fold increase over control) and four differ-
ent 27 kd proteins (A, 3.0 ± 0.8-fold; B, 1.6 ± 0.6-fold; C,
1.7 ± 0.5-fold; and D, 2.3 ± 0.9-fold increase over con-
trol). The four 27 kd phosphoproteins were immunoreac-
tive with anti-HSP27 antibodies (C and D). An immuno-
reactive isoform of HSP27 was not phosphorylated (NP).
The relative mobility of the proteins is indicated by the
molecular weight markers on the left, and the direction of
the isoelectric gradient is indicated by the + and – at the
top of the gels.
strips (data not shown), which suggests that the
phosphorylation of HSP27 led to a shift of HSP27
from the basic nonphosphorylated form to the more
acidic phosphorylated isoforms of HSP27.
DISCUSSION
In the setting of arterial injury, thrombin may act
locally to produce vasospasm. Thrombin stimulation
of bovine carotid artery smooth muscle leads to
rapidly developing, sustained contractions. Activation
of MAP kinase has been implicated in modulating
sustained vascular smooth muscle contraction, and
MAP kinase has been implicated in activating of
MAPKAP2 kinase. We sought to determine whether
activation of MAPKAP2 kinase occurred in bovine
carotid arteries stimulated with thrombin. Thrombin
stimulation of carotid artery smooth muscle led to
activation of MAPKAP2 kinase and to increases in the
phosphorylation of multiple isoforms of 27 kd pro-
teins (Figs. 2 and 3). Because HSP27 is a substrate for
MAPKAP2 kinase, we sought to determine whether
the 27 kd phosphoproteins were HSP27. Immuno-
blotting with anti-HSP27 antibodies identified multi-
ple isoforms of HSP27 that had mobility on two-
dimensional gels similar to that of the 27 kd phos-
phoproteins (Fig. 3). Phosphorylation of HSP27 in
vitro with MAPKAP2 kinase also led to a pattern of
migration similar to that of the 27 kd proteins (Fig.
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 5 Brophy et al. 967
Fig. 4. Recombinant HSP27 (0.5 µg) was phosphorylat-
ed in vitro by MAPKAP2 kinase (0.1 U). The proteins
were separated on two-dimension gels, and autoradi-
ographs were obtained. The relative mobility and isoelec-
tric focusing points of recombinant HSP27 phosphorylat-
ed in vitro by MAPKAP2 kinase were similar to the pat-
terns that occurred in carotid artery smooth muscle
stimulated by thrombin in situ. The relative mobility of
the proteins is indicated by the molecular weight markers
on the left, and the direction of the isoelectric gradient is
indicated by the + and – at the top.
Fig. 5. Phosphopeptide maps of the HSP27 isoforms.
The spots (A, B, C, and D) corresponding to the various
isoforms of HSP27 (HSP27A, HSP27B, HSP27C, and
HSP27D) were excised from two-dimension gels.
Proteolytic digests of the proteins were performed accord-
ing to the method of Cleveland et al.,21 the peptides were
separated on a 15% SDS-PAGE gel, and autoradiographs
were obtained. The patterns of phosphorylated peptides
from each of the isoforms were similar. This autoradi-
ograph is representative of three separate experiments.
4). Taken together, these data suggest that HSP27
represents a major phosphoprotein in vascular
smooth muscle and that thrombin stimulation leads
to activation of MAPKAP2 kinase and increases in the
phosphorylation of HSP27.
HSP27 is present in vascular smooth musle in at
least five isoforms with different isoelectric focusing
points (Fig. 3). Four of the isoforms (HSP27A,
HSP27B, HSP27C, HSP27D) are phosphorylated,
and there is a more basic nonphosphorylated pool of
HSP27 in vascular smooth muscle. There was con-
siderable basal phosphorylation of all four isoforms
of HSP27 in unstimulated bovine carotid artery
smooth muscle. There was a significant increase in
the phosphorylation of all four isoforms after throm-
bin stimulation (1.5- to 3.0-fold increase over con-
trol values). Thrombin stimulation led to a decrease
in the amount of HSP27 that was in the nonphos-
phorylated pool (Fig. 6), indicating that phosphory-
lation of HSP27 led to a shift from the basic non-
phosphorylated to the more acidic phosphorylated
pools of HSP27. The four isforms produced similar
peptide maps on Staph V8 proteolytic digests (Fig.
5), suggesting that they share significant homology
and are phosphorylated in related peptide sequences.
Thrombin stimulation leads to activation of
MAP kinase in fibroblasts23 and an increase in the
tyrosine phosphorylation of MAP kinase (which is
associated with activation) in carotid artery smooth
muscle.2 Although caldesmon has been implicated as
the MAP kinase substrate that modulates sustained
smooth muscle contraction,5,24 the phosphorylation
of HSP27 may represent an additional regulatory
pathway. Some reports have implicated HSP27 in
platelet activation and in modulating gastrointestinal
smooth muscle contractile responses.9,10 HSP27
may modulate cytomorphologic changes by a direct
interaction with actin. HSP27 is an actin-binding
protein that modulates actin filament dynamics.13-15
We also demonstrated that another small HSP,
HSP20, is phosphorylated in association with cyclic
nucleotide-dependent vasorelaxation.25
In cultured cells, HSP27 expression is increased
by heat shock, chemical stressors, and cytokine stim-
ulation. However, HSP27 is constituitively present
and relatively abundant in skeletal and cardiac mus-
cle tissue.26 Expression of HSP27 increases after
continuous motor nerve stimulation and decreases
with denervation of skeletal muscle.27 Expression of
HSP27 is increased, specifically in adrenal tissue and
vascular smooth muscle, in response to restraint
stress in rats.28 Induction of another HSP, HSP70,
occurs in the adrenal cortex and vasculature of rats
after air jet stress, and this cellular response to stress
is associated with the development of significant
hypertension.29 Taken together, these data suggest
the possibility that cellular stress may lead to alter-
ations in the vasomotor responses of the vascular
smooth muscle by means of changes in the expres-
sion of small HSPs.
The relative abundance of HSP27 in muscle tis-
sue, the association of increased phosphorylation of
HSP27 with thrombin-induced contraction, and
demonstration that “HSP27 kinase” (MAPKAP2
kinase) is activated by thrombin stimulation of vas-
cular smooth muscles support a role for HSP27 in
the cellular physiology of contraction and possibly in
vasospasm.
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